This site is intended for health professionals only!

Published on 2 July 2007

Share this story:

Sanofi pulls US rimonabant application


It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine